Trisalus Life Sciences Stock Market Value
| TLSI Stock | 4.94 0.07 1.40% |
| Symbol | TriSalus |
Is there potential for Health Care Equipment & Supplies market expansion? Will TriSalus introduce new products? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
Investors evaluate TriSalus Life Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating TriSalus Life's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause TriSalus Life's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, TriSalus Life's market price signifies the transaction level at which participants voluntarily complete trades.
TriSalus Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TriSalus Life's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TriSalus Life.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in TriSalus Life on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding TriSalus Life Sciences or generate 0.0% return on investment in TriSalus Life over 90 days. TriSalus Life is related to or competes with Profound Medical, MaxCyte, Perspective Therapeutics, Anteris Technologies, Prenetics Global, LENSAR, and Nano X. TriSalus Life is entity of United States More
TriSalus Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TriSalus Life's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TriSalus Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 26.66 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 5.49 |
TriSalus Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TriSalus Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TriSalus Life's standard deviation. In reality, there are many statistical measures that can use TriSalus Life historical prices to predict the future TriSalus Life's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.17) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TriSalus Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TriSalus Life March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.2 | |||
| Coefficient Of Variation | (1,724) | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.74 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 26.66 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 5.49 | |||
| Skewness | 0.5621 | |||
| Kurtosis | 3.64 |
TriSalus Life Sciences Backtested Returns
TriSalus Life Sciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0897, which indicates the firm had a -0.0897 % return per unit of risk over the last 3 months. TriSalus Life Sciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TriSalus Life's Risk Adjusted Performance of (0.04), variance of 20.74, and Coefficient Of Variation of (1,724) to confirm the risk estimate we provide. The entity has a beta of 1.64, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TriSalus Life will likely underperform. At this point, TriSalus Life Sciences has a negative expected return of -0.41%. Please make sure to validate TriSalus Life's potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if TriSalus Life Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
TriSalus Life Sciences has very weak reverse predictability. Overlapping area represents the amount of predictability between TriSalus Life time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TriSalus Life Sciences price movement. The serial correlation of -0.1 indicates that less than 10.0% of current TriSalus Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out TriSalus Life Correlation, TriSalus Life Volatility and TriSalus Life Performance module to complement your research on TriSalus Life. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
TriSalus Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.